Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

BACKGROUND: Prior to the approval of sorafenib, hepatic arterial infusion chemotherapy (HAIC) was offered to patients with advanced hepatocellular carcinoma (HCC) in East Asia, particularly Japan. According to the Japanese guidelines, HAIC is recommended as one of the treatment options in patients w...

詳細記述

保存先:
書誌詳細
出版年:Liver Cancer
主要な著者: Ueshima, Kazuomi, Ogasawara, Sadahisa, Ikeda, Masafumi, Yasui, Yutaka, Terashima, Takeshi, Yamashita, Tatsuya, Obi, Shuntaro, Sato, Shinpei, Aikata, Hiroshi, Ohmura, Takumi, Kuroda, Hidekatsu, Ohki, Takamasa, Nagashima, Kengo, Ooka, Yoshihiko, Takita, Masahiro, Kurosaki, Masayuki, Chayama, Kazuaki, Kaneko, Shuichi, Izumi, Namiki, Kato, Naoya, Kudo, Masatoshi, Omata, Masao
フォーマット: Artigo
言語:Inglês
出版事項: S. Karger AG 2020
主題:
Original Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548914/
https://ncbi.nlm.nih.gov/pubmed/33083282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000508724
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料